280 related articles for article (PubMed ID: 35078501)
21. A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
Xu M; Zhang C; Liu Y; Chen S; Zheng Y; Wang Z; Cao R; Wang J
Virus Res; 2022 May; 313():198740. PubMed ID: 35271886
[TBL] [Abstract][Full Text] [Related]
22. A gD&gC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant.
Zhang C; Liu Y; Chen S; Qiao Y; Guo M; Zheng Y; Xu M; Wang Z; Hou J; Wang J
BMC Vet Res; 2019 Jan; 15(1):2. PubMed ID: 30606159
[TBL] [Abstract][Full Text] [Related]
23. Pseudorabies virus (PRV) strain with defects in gE, gC, and TK genes protects piglets against an emerging PRV variant.
Lin J; Li Z; Feng Z; Fang Z; Chen J; Chen W; Liang W; Chen Q
J Vet Med Sci; 2020 Jun; 82(6):846-855. PubMed ID: 32336701
[TBL] [Abstract][Full Text] [Related]
24. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China.
Luo Y; Li N; Cong X; Wang CH; Du M; Li L; Zhao B; Yuan J; Liu DD; Li S; Li Y; Sun Y; Qiu HJ
Vet Microbiol; 2014 Nov; 174(1-2):107-15. PubMed ID: 25293398
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of the Bartha-K61 vaccine and a gE
Wang J; Cui X; Wang X; Wang W; Gao S; Liu X; Kai Y; Chen C
Res Vet Sci; 2020 Feb; 128():16-23. PubMed ID: 31707096
[TBL] [Abstract][Full Text] [Related]
26. Efficacy evaluation of two live virus vaccines against an emerging pseudorabies virus variant.
Wang M; Wang L; Zhao Q
Pol J Vet Sci; 2019 Dec; 22(4):639-645. PubMed ID: 31867931
[TBL] [Abstract][Full Text] [Related]
27. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets.
Zhang C; Guo L; Jia X; Wang T; Wang J; Sun Z; Wang L; Li X; Tan F; Tian K
Vaccine; 2015 May; 33(21):2432-7. PubMed ID: 25865469
[TBL] [Abstract][Full Text] [Related]
28. Pathogenicity and immunogenicity of a gI/gE/TK/UL13-gene-deleted variant pseudorabies virus strain in swine.
Lv L; Liu X; Jiang C; Wang X; Cao M; Bai J; Jiang P
Vet Microbiol; 2021 Jul; 258():109104. PubMed ID: 34004569
[TBL] [Abstract][Full Text] [Related]
29. Comparative pathogenicity and immunogenicity of triple and double gene-deletion pseudorabies virus vaccine candidates.
Dong J; Bai J; Sun T; Gu Z; Wang J; Sun H; Jiang P
Res Vet Sci; 2017 Dec; 115():17-23. PubMed ID: 28130999
[TBL] [Abstract][Full Text] [Related]
30. Emergence of a novel pathogenic recombinant virus from Bartha vaccine and variant pseudorabies virus in China.
Bo Z; Miao Y; Xi R; Gao X; Miao D; Chen H; Jung YS; Qian Y; Dai J
Transbound Emerg Dis; 2021 May; 68(3):1454-1464. PubMed ID: 32857916
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of immunogenicity of gene-deleted and subunit vaccines constructed against the emerging pseudorabies virus variants.
Zhang HL; Zhang RH; Liu G; Li GM; Wang FX; Wen YJ; Shan H
Virol J; 2023 May; 20(1):98. PubMed ID: 37221518
[TBL] [Abstract][Full Text] [Related]
32. Outbreak of variant pseudorabies virus in Bartha-K61-vaccinated piglets in central Shandong Province, China.
Hu D; Zhang Z; Lv L; Xiao Y; Qu Y; Ma H; Niu Y; Wang G; Liu S
J Vet Diagn Invest; 2015 Sep; 27(5):600-5. PubMed ID: 26179102
[TBL] [Abstract][Full Text] [Related]
33. Variations in glycoprotein B contribute to immunogenic difference between PRV variant JS-2012 and Bartha-K61.
Yu ZQ; Tong W; Zheng H; Li LW; Li GX; Gao F; Wang T; Liang C; Ye C; Wu JQ; Huang Q; Tong GZ
Vet Microbiol; 2017 Sep; 208():97-105. PubMed ID: 28888658
[TBL] [Abstract][Full Text] [Related]
34. A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
Luo C; Wang Q; Guo R; Zhang J; Zhang J; Zhang R; Ma X; Wang P; Adam FEA; Zeshan B; Yang Z; Zhou Y; Wang X
Virus Res; 2022 Dec; 322():198937. PubMed ID: 36174845
[TBL] [Abstract][Full Text] [Related]
35. Pathogenicity and immunogenicity of a quadruple gene-deleted pseudorabies virus variant as a vaccine candidate.
Ma Z; Jiang C; Liu D; Gao Y; Bai J; Jiang P; Liu X
Vet Microbiol; 2024 Jan; 288():109931. PubMed ID: 38056181
[TBL] [Abstract][Full Text] [Related]
36. A triplex real-time PCR for differential detection of classical, variant and Bartha-K61 vaccine strains of pseudorabies virus.
Meng XY; Luo Y; Liu Y; Shao L; Sun Y; Li Y; Li S; Ji S; Qiu HJ
Arch Virol; 2016 Sep; 161(9):2425-30. PubMed ID: 27316441
[TBL] [Abstract][Full Text] [Related]
37. Emergence of a Pseudorabies virus variant with increased virulence to piglets.
Tong W; Liu F; Zheng H; Liang C; Zhou YJ; Jiang YF; Shan TL; Gao F; Li GX; Tong GZ
Vet Microbiol; 2015 Dec; 181(3-4):236-40. PubMed ID: 26507829
[TBL] [Abstract][Full Text] [Related]
38. Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus.
Zhou J; Li S; Wang X; Zou M; Gao S
Vaccine; 2017 Feb; 35(8):1161-1166. PubMed ID: 28131396
[TBL] [Abstract][Full Text] [Related]
39. Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals.
Cong X; Lei JL; Xia SL; Wang YM; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Vet Microbiol; 2016 Jan; 182():170-7. PubMed ID: 26711045
[TBL] [Abstract][Full Text] [Related]
40. The Inactivated
Jin YL; Yin D; Xing G; Huang YM; Fan CM; Fan CF; Qiu XH; Dong WR; Yan Y; Gu JY; Zhou JY
Front Microbiol; 2022; 13():943707. PubMed ID: 35992698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
